Ionis Pharmaceuticals Inc (STU:ISI)
€ 34.62 0.13 (0.38%) Market Cap: 5.44 Bil Enterprise Value: 4.45 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 59/100

Ionis Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript

Nov 16, 2020 / 09:00PM GMT
Release Date Price: €44.16 (+1.72%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

Great. Thanks very much, everybody, for those who continue to dial into the fireside chat this afternoon. I am happy to be moderating a discussion here with executives from Ionis Pharmaceuticals. With me, we have CEO, Brett Monia; and CFO, Beth Hougen, who I'm sure folks style they know quite well. Maybe we can start and just have Brett give a 3 to 5-minute overview, set the stage for Ionis' key pipeline events coming off recent progress, and then we can get into Q&A. How does that sound?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sounds great, Paul. It's a pleasure to be here. So yes, we're very excited about Ionis and where we're headed in the future. Obviously, a lot of news this year and a lot of pipeline events.

I mean, recently, we announced several Phase IIb starts of our Factor XI program, our HBV program. And then most recently, vupanorsen with Pfizer on angiopoietin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot